Servei d'Otorrinolaringologia, Hospital Comarcal d'Inca, Carretera Vella de Llubí, 07300, Inca, Illes Balears, Spain.
Servei d'Otorrinolaringologia, Hospital Universitari Son Espases, Palma, Illes Balears, Spain.
Curr Allergy Asthma Rep. 2020 Jun 3;20(7):28. doi: 10.1007/s11882-020-00917-5.
The purposes of the review are as follows: (1) to define acute rhinosinusitis (ARS) and their phenotypes, (2) to highlight the ARS management according to international guidelines, (3) to compare the physicians' management with the ARS guideline recommendations, and (4) to report ARS socioeconomic burden.
Bacterial and non-bacterial ARS have similar symptoms, although they can be discriminated by using a combination of specific signs and symptoms. The prescription of antibiotics should be limited to clearly suspected bacterial ARS. There is an overuse of diagnosis tools and treatment prescriptions. The total cost per ARS episode in Europe is over €1000. ARS is mainly an inflammatory disease triggered by viral infection, and few cases end up developing bacterial infection. In most of the cases, it is a self-resolving disease which diagnosis is mainly clinical and the treatment symptomatic. The incidence of complications is low and independent of antibiotic use. There is a high socioeconomic burden associated to ARS.
本文的目的如下：（1）定义急性鼻-鼻窦炎（ARS）及其表型，（2）根据国际指南强调 ARS 的管理，（3）比较医师管理与 ARS 指南建议，（4）报告 ARS 的社会经济负担。
细菌和非细菌性 ARS 具有相似的症状，尽管可以通过特定的体征和症状组合来区分。抗生素的处方应仅限于明确怀疑的细菌性 ARS。诊断工具和治疗处方的使用存在过度的情况。在欧洲，每例 ARS 发作的总成本超过 1000 欧元。ARS 主要是由病毒感染引发的炎症性疾病，很少有病例最终发展为细菌感染。在大多数情况下，它是一种自限性疾病，诊断主要是临床诊断，治疗是对症治疗。并发症的发生率较低，与抗生素的使用无关。ARS 与高社会经济负担相关。
